Publications by authors named "Debra Swanson"

Claim this Profile
I
In vivo protection of activated Tyr22-dihydrofolate reductase gene-modified canine T lymphocytes from methotrexate.
Jennifer L Gori, Brian C Beard, Nathaniel P Williams, Christina Ironside, Debra Swanson

J Gene Med· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo.
Megan M Multhaup, Sweta Gurram, Kelly M Podetz-Pedersen, Andrea D Karlen, Debra L Swanson

DNA Cell Biol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer.
Megan Multhaup, Andrea D Karlen, Debra L Swanson, Andrew Wilber, Nikunj V Somia

Hum Gene Ther· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection of mice from methotrexate toxicity by ex vivo transduction using lentivirus vectors expressing drug-resistant dihydrofolate reductase.
Jennifer L Gori, Kelly Podetz-Pedersen, Debra Swanson, Andrea D Karlen, Roland Gunther

J Pharmacol Exp Ther· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
Lalitha R Belur, Rohaizah I James, Chad May, Miechaleen D Diers, Debra Swanson

J Pharmacol Exp Ther· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis